Invention Publication
- Patent Title: SULFONAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING MENTAL ILLNESS
-
Application No.: US17928032Application Date: 2021-04-05
-
Publication No.: US20230212121A1Publication Date: 2023-07-06
- Inventor: Minsoo Song , Chun Young Im , Ga Young Park , Eun Bi Ko , Jihee Kang , Seri Bae , Soong-Hyun Kim , Yoojin Park , Eunhye Lee , Yujeong Choi , Jeongmin Joo , Sion Lee , Chan Young Shin , Kyoung Ja Kwon , Hee Jong Hwang , Suresh Paudel , Se Jin Jeon , Kyu Suk Cho
- Applicant: DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION , TRINEURO
- Applicant Address: KR Daegu
- Assignee: DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION,TRINEURO
- Current Assignee: DAEGU-GYEONGBUK MEDICAL INNOVATION FOUNDATION,TRINEURO
- Current Assignee Address: KR Daegu
- Priority: KR 20200065505 2020.05.29 KR 20210041812 2021.03.31
- International Application: PCT/KR2021/004197 2021.04.05
- Date entered country: 2023-01-13
- Main IPC: C07D211/14
- IPC: C07D211/14 ; C07D401/12 ; C07D215/36 ; C07C307/02 ; C07D401/04
Abstract:
Disclosed are a sulfonamide derivative and a pharmaceutical composition comprising same as an active ingredient for use in preventing or treating mental illness. The derivative is superbly effective in a triple reuptake inhibitor of serotonin, norepinephrine, and dopamine, and thus can be effectively used in treating mental illness.
Information query
